One ARK Invest exchange-traded fund run by ETF star Cathie Wood bought over 150,000 shares of Pfizer Inc. (NYSE: PFE) on Wednesday, as the price of this fund was flat in Wednesday’s session. It is still up a fair amount in the past year.

ARK Genomic Revolution ETF (NYSEARCA: ARKG) added 158,788 shares of Pfizer. At Wednesday’s closing price, this would have valued this purchase at roughly $7.8 million. This is only a small fraction of the total holdings. The fund is up 31% over the past 52 weeks.

Check out all the ARK Invest buys for Wednesday:

Fund	Ticker	Company	Shares
ARKF	PATH	UiPath	80,400
ARKF	PLTR	Palantir Technologies	93,189
ARKF	Z	Zillow	21,507
ARKG	RPTX	Repare Therapeutics	3,791
ARKG	SURF	Surface Oncology	41,741
ARKG	QSI	Quantum-Si	130,116
ARKG	VCYT	Veracyte	33,477
ARKG	PFE	Pfizer	158,788
ARKG	NVTA	Invitae	242,234
ARKG	ZY	Zymergen	34,547
ARKG	MASS	908 Devices	21,511
ARKG	EXAS	Exact Sciences	134,729
ARKG	DYNS	Dynamics Special Purpose	92,700
ARKG	CRSP	CRISPR Therapeutics	19,000
ARKG	SMFR	Sema4	307,823
ARKK	TSP	TuSimple	130,152
ARKK	SRNG	Soaring Eagle Acquisition	180,000
ARKK	SGFY	Signify Health	120,721
ARKK	NVTA	Invitae	118,534
ARKK	NTLA	Intellia Therapeutics	67,593
ARKK	CRSP	CRISPR Therapeutics	18,436
ARKK	BEAM	Beam Therapeutics	4,174
ARKK	FATE	Fate Therapeutics	102
ARKK	EDIT	Editas Medicine	17,973
ARKQ	AVAV	Aerovironment	19,814
ARKQ	BLDE	Blade Air Mobility	14,731
ARKQ	KMTUY	Komatsu	103,400
ARKQ	MKFG	Markforged	102,260
ARKQ	TSP	TuSimple	90,773
ARKW	CND	Concord Acquisition	20,000
ARKW	GENI	Genius Sports	241,657
ARKW	KVSB	Khosla Venture Acquisition II	9,053
ARKW	LPSN	LivePerson	46,116

Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St.

Get Our Free Investment Newsletter

I have read, and agree to the Terms of Use

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.